12/11/2025 9:20:39 PM Antitrust Risks and Compliance Strategies in Intellectual Property Portfolio Management By Kate Gehl Richard Lee Ellen Matheson Kitty Young +1 more... Show less This article analyzes how intellectual property portfolio management can simultaneously promote innovation and present potential...
12/4/2025 3:50:10 PM FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation By Oyvind Dahle FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,...
12/1/2025 4:02:10 PM USPTO Updates Guidance on Inventorship in AI-assisted Inventions By Randy Pummill USPTO Director Squires released updated guidance on AI-assisted inventions. The new guidance states that AI-assisted inventions are...
10/27/2025 4:43:42 PM AI in Health Care and Biotechnology: Promise, Progress, and Challenges By Antoinette Konski Artificial intelligence (AI) is transforming health care and biotechnology, propelling advancements in drug discovery, genomics, medical...
10/20/2025 6:02:57 PM From Rare Genes to Precision Health: $80M in New NIH Funding to Study Longer, Healthier Lives By Antoinette Konski The Long Life Family Study (LLFS) is a multi-decade, multicenter research program designed to uncover the genetic and biological factors...
10/9/2025 5:52:46 PM California Governor Newsom Signs Browser Opt-out Signal Bill By Steve Millendorf On October 8, California Governor Newsom signed AB 566, which adds a section to the California Privacy Protection Agency (CCPA) to...
10/8/2025 2:58:09 PM From Abstract to Applied: How Desjardins Can Reframe Patent Protection for AI in Health Care By Antoinette Konski Evan Glass For a decade, innovators at the intersection of artificial intelligence (AI) and precision medicine have faced a stubborn paradox: the...
9/29/2025 1:42:09 PM From Patent to Patient: FDA Policy Ideas to Protect and Speed Medical Innovation By Antoinette Konski A Blueprint for FDA: Recommendations to Improve Innovation and Access [1] (FDA Blueprint) is a timely white paper authored by University...
8/21/2025 3:36:11 PM Securing Value: Patent Strategies for AI-Accelerated Drug Repurposing By Oyvind Dahle Drug development can be slow, costly, and risky, often taking more than a decade and billions of dollars to bring a single therapy to the...
8/7/2025 1:53:11 PM USPTO Addresses Reports of New Patent Fee Structure By Randy Pummill In a recent webinar hosted by the Licensing Executives Society, U.S. Patent and Trademark Office acting Director Coke Morgan Stewart...
7/30/2025 3:32:08 PM US Considers Charging Fees Based on Patent Value By Randy Pummill The Trump administration is reportedly considering a proposal to charge patent holders a fee based on the value of their patents,...
7/14/2025 1:59:39 PM The Patent Eligibility Restoration Act and Life Sciences Innovation By Antoinette Konski The biotechnology and life science sectors underpin breakthroughs in health care, agriculture, and environmental sustainability by...
6/18/2025 1:53:09 PM Legal Reasoning Still a Struggle for LLMs By Austin Kim The authors in this paper created a benchmark including long-form, open-ended questions and multiple-choice questions to evaluate the...
5/28/2025 1:52:09 PM Rethinking University Research: Innovating the Innovation Ecosystem to Support Life Sciences and Personalized Medicine By Antoinette Konski Personalized medicine—tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environment—is...
5/13/2025 8:28:39 PM Fed. Circuit Provides New Guidance on Invention Conception By Randy Pummill In litigation to establish inventorship of the CRISPR gene editing technique, the Fed. Circuit provided additional guidance on how to...
3/10/2025 8:52:42 PM Beyond the Polanyi Paradox: How Human-Aware AI Unlocks Creativity And Breakthrough Discoveries By Oyvind Dahle Artificial intelligence (AI) has transformed scientific research and innovation, yet as previously discussed, the Polanyi Paradox remains...